InvestorsHub Logo

TheWayISeeIt

02/21/21 3:28 AM

#347810 RE: thefamilyman #347808

I love the idea of “going it alone” and forging our own paths to the exclusion of Big Pharma but it’s completely unrealistic. I’ve been an investor in CYDY for a long time and part of what’s held that back is the CEO’s reluctance to engage with BP. Conversely, HGEN seems to have the right idea.
On the basis that BP has significant influence on the FDA, you need to play ball with them or it just won’t happen.
IMHO Leo understands that.
I can see an early BO upon positive data, possibly from $GILD or $PFE (given senior management connections). It’s not out with the realms of possibility that a State (e.g. Russia) could launch a BO.

I’d personally take a BO in the $5-10 range.

Lemoncat

02/21/21 10:28 AM

#347846 RE: thefamilyman #347808

You can give 80% to the partner and get a bunch of money up front, or you can dilute the entire pipeline 80% to raise money to have a chance at passing phase 3.

A little pharmas get hosed the first deal. Its how they become self-sufficient. Unfortunately it will take two deals in our case.

Go IPIX!